Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy

Published:2017-09-14 Issue:4 Volume:24 Page:217-223
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Benson Merrill D.¹²,Dasgupta Noel R.³,Rissing Stacy M.⁴,Smith Jessica⁴,Feigenbaum Harvey³

Affiliation:

1. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA;

2. RLR Veterans Affairs Medical Center, Indianapolis, IN, USA;

3. Department of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA;

4. Department of Radiology, Indiana University School of Medicine, Indianapolis, IN, USA

Funder

RLR Veterans Affairs Medical Research

Marion E. Jacobson Fund

Machado Family Research Fund

Aldo Research Fund

Indiana University Foundation Accounts

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2017.1374946

Reference19 articles.

2. The molecular biology and clinical features of amyloid neuropathy

3. Fibril in senile systemic amyloidosis is derived from normal transthyretin.

4. Systemic Cardiac Amyloidoses

5. Rate of Progression of Transthyretin Amyloidosis

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotype and prognostic factors in geriatric and non‐geriatric patients with transthyretin cardiomyopathy;ESC Heart Failure;2024-07-17

2. Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review;Journal of Comparative Effectiveness Research;2024-07

3. Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy;Expert Opinion on Drug Discovery;2024-01-27

4. Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review;Biomedicines;2023-12-21

5. Non-coding RNA therapeutics in cardiovascular diseases and risk factors: Systematic review;Non-coding RNA Research;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3